Dr. GG Formula
Natural health product licensed in Canada
- Licence holder
- Dr. Hamiras Inc.
- NPN or DIN-HM
- 80079929
- Status
- Inactive licence
- Licence date
- 8 September 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Racine | 25 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome | 50 milligramme | Not calculated |
| Centella asiatica Source : Sommité | 50 milligramme | Not calculated |
| Camellia sinensis Source : Feuille | 25 milligramme | Not calculated |
| Curcuma longa Source : Rhizome | 50 milligramme | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme | 100 milligramme | Not calculated |
| Cinnamomum aromaticum Source : Écorce (branche) | 50 milligramme | Not calculated |
| Cinnamomum aromaticum Source : Ecorce (tronc) | 50 milligramme | Not calculated |
| Cinnamomum aromaticum Source : Écorce (tige) | 50 milligramme | Not calculated |
| Coptis chinensis Source : Rhizome | 50 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Farine de riz brun, Stéarate de magnésium, Pullulane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. (Traditionally) used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Effets indésirables connus
Hypersensitivity / allergy may occur; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have diabetes. If you have liver or gall bladder diseases, and / or intestinal obstruction, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80079929
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.